What service do you need? Contact Request

NCT06825702

Safety, Tolerability and Efficacy of Intravitreal KIO-104 in Patients With Macular Edema

← Hub

Registry fields

Overall status: RECRUITING
Conditions: Macular Edema
Study type: INTERVENTIONAL
Phase: PHASE2
Primary purpose: TREATMENT
Intervention type: DRUG
Interventions: KIO-104
Lead sponsor: Kiora Pharmaceuticals, Inc. (INDUSTRY)

Cached at: 2026-09-10 09:08:10

View on ClinicalTrials.gov

Brief summary

This is a multi-center, open label study to assess the safety, tolerability, and efficacy of KIO-104 administered by IVT injection to the study eye of eligible participants with macular edema.

Contact

Need a report or Korean medical writing based on this trial?

Request a report Medical writing Custom research report